U.S. Stem Cell, Inc.
Giá lên

$USRM From .0045 Onwards She is Ready for the 4th Leg Up

213
By far one of my top 3 favorite stocks so far this year, our Bio baby has proven her stamina. She has hit the .08 support at triple bottom and is ready for a 4th massive move upwards. With Institutional investors now throwing upwards of $5 million in financing at her for a stake in what is to be a potential FDA approval after a more than likely RMAT approval, its no wonder she is up almost 20,000% as of today from where we first found her. This is a perfect time to get back in if you already sold and are looking for another entry point for the next leg up.

Thông báo miễn trừ trách nhiệm

Thông tin và các ấn phẩm này không nhằm mục đích, và không cấu thành, lời khuyên hoặc khuyến nghị về tài chính, đầu tư, giao dịch hay các loại khác do TradingView cung cấp hoặc xác nhận. Đọc thêm tại Điều khoản Sử dụng.